Datasheet for Pharmacopoeia Certificates in Weighing

Certificates USP 41 & Ph. Eur. 2.1.7

in Laboratory Weighing

USP Chapter 41 weighing requirements

USP Chapter 41 Weighing Requirements

Weighing in Pharmaceutical Quality Control According to U.S. Pharmacopeia Guidelines

Routine Testing of Laboratory Balances

Routine Testing of Balances and Scales Guide

How to Ensure Accurate Weighing Results Every Day? Put Routine Balance Testing into Practice

SOP for Testing Laboratory Balance

Standard Operating Procedures (SOPs) for Balance and Scale Testing

Recommendations on Balance Sensitivity, Eccentricity and Repeatability Testing

1. Who needs to comply with USP, Ph. Eur. 2.1.7., and JP 9.62?

The chapters are legally binding for both local pharmaceutical companies and importers to the respective countries where they are enacted. They specifically target users working in pharmaceutical quality control who use balances for analytical purposes. The chapters are not applicable to the manufacturing of pharmaceuticals.

2. How does the Accuracy Calibration Certificate (ACC) fulfill the calibration requirements of those Pharmacopoeia Chapters?

Typically, a calibration certificate indicates measurements for repeatability, eccentricity and error of indication. The ACC provides results for all these parameters, as well as:

  • Measurement uncertainty
  • As Found/As Left performance of the weighing instrument

The ACC indicates the measurement uncertainty for error of indication test points. The indication of measurement uncertainty in a calibration certificate is stipulated in the various Pharmacopoeias. In addition, the ACC always indicates the As Found/As Left test results.

Note that ACC does not provide specific assessments for repeatability and accuracy, including a statement of compliance with the various Pharmacopoeia Chapters. This is covered by the Certificate Pharmacopoeias.

3. Do the Pharmacopoeia Chapters affect only analytical balances or balances used for analytical purposes in general?

There is an official definition: An analytical balance starts with a readability of 0.1 mg or smaller.

However, the framework of the pharmacopoeia regulations considers devices that are used for analytical purposes. If you use a precision balance for analytical purposes (which is rare but might occur) then the precision balance would also have to follow USP, JP, and European Pharmacopoeia regulations.

4. How often do I have to perform the performance checks?

For example, General Chapter 2.1.7 stipulates that specific performance checks must be carried out in between calibrations. While calibrations are usually performed annually or in intervals of three to six months, performance checks are typically performed more often, depending on the risk of the application and the quality requirements of the user. However, it is still left up to each company to define appropriate intervals for calibration and performance checks based on their own quality considerations and the risk of their specific applications. GWP® Verification fills this gap and provides a clear risk-based test strategy for suggested calibration frequencies, individual routine tests, test weights, test weight classes, and test weight recalibration intervals.